Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Antimicrob Chemother ; 63(5): 998-1005, 2009 May.
Artigo em Inglês | MEDLINE | ID: mdl-19299471

RESUMO

BACKGROUND: Switching a thymidine analogue to a non-thymidine analogue or changing to a nucleoside-sparing regimen has been shown to partially reverse peripheral lipoatrophy. The current study evaluated both approaches. METHODS: Subjects at 15 AIDS Clinical Trial Group sites receiving thymidine analogue stavudine- or zidovudine-containing regimens with plasma HIV RNA < or =500 copies/mL and lipoatrophy were prospectively randomized to: (i) switch the thymidine analogue to abacavir; (ii) discontinue all antiretrovirals and switch to lopinavir/ritonavir plus nevirapine (LPV/r+NVP); or (iii) delay switching for 24 weeks (ClinicalTrials.gov identifier: NCT00028314). Single-slice computer tomography of mid-thigh and abdominal fat and metabolic and virological/immunological parameters were measured at baseline and weeks 24 and 48. RESULTS: Among the 101 patients enrolled, there were significant subcutaneous thigh fat and subcutaneous abdominal tissue (SAT) increases over time and decreases in visceral adipose tissue to total adipose tissue (VAT:TAT) ratios for both interventions, and a decrease in VAT for abacavir. CD4 increased in the LPV/r+NVP arm. LPV/r+NVP had a significantly shorter time to grade 3 or higher toxicity (P = 0.007), but discontinuation rates were similar. Glucose levels did not change, but insulin decreased in the LPV/r+NVP arm. Lipids tended to increase in the LPV/r+NVP arm. CONCLUSIONS: Switching stavudine or zidovudine to a non-thymidine analogue or changing to a nucleoside reverse transcriptase inhibitor-sparing regimen is associated with qualitatively similar improvements in thigh fat, SAT and VAT:TAT ratio at 48 weeks. Abacavir also resulted in VAT reductions and LPV/r+NVP resulted in CD4 count increases.


Assuntos
Fármacos Anti-HIV/efeitos adversos , Fármacos Anti-HIV/uso terapêutico , Infecções por HIV/tratamento farmacológico , Síndrome de Lipodistrofia Associada ao HIV/induzido quimicamente , Gordura Intra-Abdominal/anormalidades , Contagem de Linfócito CD4 , Didesoxinucleosídeos/efeitos adversos , Didesoxinucleosídeos/uso terapêutico , Feminino , Infecções por HIV/complicações , Infecções por HIV/imunologia , Infecções por HIV/virologia , Humanos , Lopinavir , Masculino , Pessoa de Meia-Idade , Nevirapina/efeitos adversos , Nevirapina/uso terapêutico , Pirimidinonas/efeitos adversos , Pirimidinonas/uso terapêutico , Radiografia Abdominal , Estavudina/efeitos adversos , Estavudina/uso terapêutico , Coxa da Perna/diagnóstico por imagem , Carga Viral , Zidovudina/efeitos adversos , Zidovudina/uso terapêutico
2.
J Opt Soc Am A Opt Image Sci Vis ; 24(9): 2932-42, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17767265

RESUMO

In a previous work [J. Opt. Soc. Am. A24, 753 (2007)], we developed a theory describing the space-time statistics of the scintillation and displacement fields of the turbulent point-spread function (PSF), which we validated using imaging data. We now expand on that work by deriving the theoretical expression for the spread fields of the PSF. We also show how the displacement and spread fields are derivable from a set of potentials, and we discuss some of the properties of those potentials.

3.
J Opt Soc Am A Opt Image Sci Vis ; 24(3): 753-63, 2007 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-17301864

RESUMO

We consider the point-spread function (PSF) of an imaging system looking through weak optical turbulence along a horizontal path through the atmospheric surface layer. From this PSF we derive a scalar total irradiance field and a center-of-mass vector field. Theoretical values are found for the space-time autocorrelation and cross-correlation functions for these fields, which are then compared with the observed correlation functions obtained from data taken at the Validation Measurements on Propagation in the Infrared and Radar (VAMPIRA) measurement trial. We discuss the meaning of these results and possible directions for future work.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...